Rheumatoid Arthritis (RA) Patient Pool Analysis in APAC: Market Size and Forecast to 2034
March 07, 2024 15:06 ET
|
Research and Markets
Dublin, March 07, 2024 (GLOBE NEWSWIRE) -- The "Rheumatoid Arthritis (RA) Patient Pool Analysis, Market Size and Market Forecast APAC - 2034" report has been added to ResearchAndMarkets.com's...
Auto-Injectors Market revenue to surpass USD 33 Billion by 2036, says Research Nester
February 21, 2024 07:00 ET
|
Research Nester
New York , Feb. 21, 2024 (GLOBE NEWSWIRE) -- The global auto-injectors market size is predicted to expand at 17% CAGR between 2024 and 2036. The market is projected to garner a revenue of USD 33...
Novotech Publishes Candidiasis and Rheumatoid Arthritis Clinical Trial Landscape Reports to Support Biotech Research Planning
February 11, 2024 21:26 ET
|
Novotech
Novotech CRO has released today two industry-leading reports on the Candidiasis and Rheumatoid Arthritis clinical trial landscapes.
Hidden Costs Of Arthritis Treatment Include Liver Damage, Medical Bills, And Serious Impacts Highlight Role of SSDI Benefits, Allsup Reports
August 29, 2023 14:30 ET
|
Allsup
Belleville, Illinois, Aug. 29, 2023 (GLOBE NEWSWIRE) -- Recent research on the effects of rheumatoid arthritis treatment highlights the challenges of treating chronic health conditions and the...
Incannex Completes Positive Pre-IND Meeting with US FDA on IHL-675A for Treatment of Rheumatoid Arthritis
July 26, 2023 07:30 ET
|
Incannex Healthcare
MELBOURNE, Australia, July 26, 2023 (GLOBE NEWSWIRE) -- Incannex Healthcare Limited (Nasdaq: IXHL) (ASX: IHL), (‘Incannex’ or the ‘Company’) a clinical-stage pharmaceutical company developing unique...
Canes and Crutches Market is expected to generate USD 1.39 Billion in Revenues by 2031 with CAGR of 3.4%: Report from TMR
July 24, 2023 13:30 ET
|
Transparency Market Research
Wilmington, Delaware, United States, July 24, 2023 (GLOBE NEWSWIRE) -- The global canes and crutches market was worth US$ 957.4 million in 2022. The global canes and crutches market is predicted to...
Incannex Receives HREC Approval for Phase 2 Clinical Trial Assessing IHL-675A for use in Treatment of Pain and Function in Rheumatoid Arthritis
July 13, 2023 08:00 ET
|
Incannex Healthcare
Highlights: Incannex has received approval from HREC for the lead site, Emeritus Research, Camberwell, VIC for the Phase 2, Blinded, Placebo Controlled Clinical Trial to Determine the Effect on Pain...
Autoinjectors Market to Grow at 16.2% CAGR and Reach USD 3.8 Bn by 2031 | Excusive Research by Transparency Market Research
June 15, 2023 10:30 ET
|
Transparency Market Research
Wilmington, Delaware, United States, June 15, 2023 (GLOBE NEWSWIRE) -- The global autoinjectors market was valued at USD 1.0 Bn in 2022 and is projected to grow at a CAGR of 16.2% from 2023 to 2031....
Incannex Company Presentation – Results from Phase 1 Clinical Trial to Assess Proprietary IHL-675A
May 03, 2023 07:30 ET
|
Incannex Healthcare
MELBOURNE, Australia, May 03, 2023 (GLOBE NEWSWIRE) -- Incannex Healthcare Ltd (Nasdaq: IXHL) (ASX: IHL) (‘Incannex’ or ‘the Company’) is pleased to announce a company presentation containing data...
Global Rheumatoid Arthritis Diagnosis Tests Strategic Business Report 2023: Repercussions of Sub Optimal Accuracy in RA Testing Drive the Need for Multiple Tests
April 10, 2023 09:48 ET
|
Research and Markets
Dublin, April 10, 2023 (GLOBE NEWSWIRE) -- The "Rheumatoid Arthritis Diagnosis Tests: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market...